Description
What It Is
Selank Spray delivers the tuftsin-derived heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) as a ready-to-use nasal spray solution. Selank has been characterized in the published preclinical research literature using an intranasal route of administration, which makes the spray format relevant for replicating those research conditions.
The compound is studied in preclinical models for its effects on GABAergic signaling, BDNF expression, and immune-CNS interface biology. The spray format is the route of administration documented in published Selank research.
Who It’s For
Researchers studying GABAergic pathway modulation, BDNF signaling, and immune-CNS interface biology via the intranasal delivery route that characterizes the Selank research literature.
Key Research Applications
- Intranasal GABAergic signaling research in animal models
- BDNF expression and neurotrophic pathway studies via nasal route
- Immune-CNS interface biology (tuftsin receptor)
- Delivery route comparison: intranasal vs. parenteral Selank administration
Handling & Storage
Supplied ready to use. No reconstitution or solvent preparation is required. Store at 2 to 8°C, protected from light, and keep the bottle upright. Avoid freeze-thaw cycles. Use within the period printed on the bottle.
—
Disclaimer: For research use only. Not for human or veterinary use. Not approved by the FDA. 21+
